Healthcare -
Biotechnology - NASDAQ - US
$ 2.64
-4.38 %
$ 416 M
Market Cap
5.0
P/E
CTMX - OPERATING INCOME
Operating Income CTMX - CytomX Therapeutics, Inc.
25 M
LAST VALUE
49.89%
2 YEAR CAGR
17.35%
5 YEAR CAGR
11.00%
10 YEAR CAGR